Lijie Tan (Jun Yin)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Neoadjuvant Chemotherapy

Top Venues

Nature medicine

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Qing Zhou, Jingnan Yuan, Kui Wu, Jun Yin, Lijie Tan
Neoadjuvant immunotherapy for resectable esophagal squamous cell carcinoma: An ace up the sleeve. Clinical and translational medicine 13 (9) (2023)
Lijie Tan, Jingnan Yuan, Yunjin Li, Yong Fang, Ruoxi Wang, Heng Jiao, Han Tang, Shaoyuan Zhang, Siyun Lin, Feng Su, Jianmin Gu, Tian Jiang, Dong Lin, Zhiliang Huang, Chaoxiang Du, Kui Wu, Lijie Tan, Qing Zhou
Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial. Nature medicine (2023)
Lijie Tan, Jingnan Yuan, Yunjin Li, Yong Fang, Ruoxi Wang, Heng Jiao, Han Tang, Shaoyuan Zhang, Siyun Lin, Feng Su, Jianmin Gu, Tian Jiang, Dong Lin, Zhiliang Huang, Chaoxiang Du, Kui Wu, Lijie Tan, Qing Zhou
Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial. Nature medicine (2023)